March 2011
Carnegie Learning Launches Middle School Math Preview
The Carnegie Learning Math Series is now available for preview via dynamic online demonstration problems, video walk-throughs and a text sampling tool. The series is designed to close the achievement gap by providing individualized learning for math students in grades 6-8 that surpasses one-size-fits-all instruction. This is a blended program that includes Carnegie Lerning Math Textbooks and MATHia software powered by Cognitive Tutor software technology. For more information, visit http://mathseries.carnegielearning.com.
Mar 31 | Permalink
Precision Therapeutics and Med Biogene to Commercialize LungExpress Dx
Precision Therapeutics and Med BioGene announced a commercialization, license and research reimbursement agreement that provides Precision with exclusive global rights to develop and commercialize LungExpress Dx. LungExpress Dx is a proprietary gene expression-based test to improve upon staging for identifying those patients with early-stage non-small-cell lung cancer (NSCLC). Sean McDonald, CEO of Precision, believes that "LungExpress Dx will be a synergistic and important addition to ChemoFx, [Precision's] flagship test. LungExpress Dx identifies early stage patients who have a poor prognosis and may benefit from chemotherapy and ChemoFx quantifies an individual patient's probable tumor response to various chemotherapeutic and biologic agents." Learn more about both "personalized medicine" solutions at www.precisiontherapeutics.com.
Mar 3 | Permalink
TOA Expands Footprint in Europe
TOA Technologies has completed the acquisition of UK distributor, Aboutime, as part of its aggressive expansion activities in Europe. TOA's solution now serves as the platform for managing more than 37 million annual appointments and deliveries. All Aboutime employees will join the TOA Europe team giving TOA an instant and significant direct presence in the UK. Learn more at www.toatech.com.
Mar 3 | Permalink
